Skip to content

Sodium oxybate

Xyrem (sodium oxybate) is a small molecule pharmaceutical. Sodium oxybate was first approved as Xyrem on 2002-07-17. It is used to treat cataplexy in the USA. It has been approved in Europe to treat cataplexy and narcolepsy. It is known to target hydroxycarboxylic acid receptor 1. Xyrem's patents are valid until 2033-03-15 (FDA).
Trade Name Xyrem
Common Name Sodium oxybate
Indication cataplexy, narcolepsy
Drug Class
Sodium oxybate
Get full access now